Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: Systematic review and meta-analysis

James W Rainsbury, Waseem Ahmed, Hazel K Williams, Sally Roberts, Vinidh Paleri, Hisham Mehanna

Research output: Contribution to journalArticlepeer-review

43 Citations (Scopus)


BACKGROUND: Human papillomavirus (HPV) positivity improves prognosis in patients with oropharyngeal squamous cell carcinoma (OPSCC). Combining HPV status with other biomarkers may improve its prognostic power. METHODS: The approach was a literature search for longitudinal studies of biomarkers in OPSCC, with systematic review and meta-analysis. RESULTS: In all, 3130 articles were identified; 32 satisfied the inclusion and exclusion criteria. On meta-analysis, there was a significant overall survival (OS) benefit for patients with HPV positive and p16 positive tumors. There was some evidence of improved OS of OPSCC patients with raised bcl2; amplification of 11q3 and loss of 16q genes; and low c-met, ki67, IMD, PLK, FHIT, nuclear surviving, or nuclear cyclin D1. However, none of these was suitable for meta-analysis. CONCLUSION: Survival from OPSCC is associated with several biomarkers, which constitute potential targets for research into improving the prognostic power of HPV in OPSCC. Larger trials are needed, with standardization of cut-points and adherence to consensus reporting guidelines. © 2012 Wiley Periodicals, Inc. Head Neck, 2012.
Original languageEnglish
Pages (from-to)1048-55
Number of pages8
JournalHead & Neck
Issue number7
Early online date20 Sept 2012
Publication statusPublished - Jul 2013


Dive into the research topics of 'Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: Systematic review and meta-analysis'. Together they form a unique fingerprint.

Cite this